Online citations, reference lists, and bibliographies.
← Back to Search

Nicotinamide Polymeric Nanoemulsified Systems: A Quality-by-design Case Study For A Sustained Antimicrobial Activity

A. Zidan, O. A. Ahmed, B. Aljaeid
Published 2016 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Nicotinamide, the amide form of vitamin B3, was demonstrated to combat some of the antibiotic-resistant infections that are increasingly common around the world. The objective of this study was to thoroughly understand the formulation and process variabilities affecting the preparation of nicotinamide-loaded polymeric nanoemulsified particles. The quality target product profile and critical quality attributes of the proposed product were presented. Plackett–Burman screening design was employed to screen eight variables for their influences on the formulation’s critical characteristics. The formulations were prepared by an oil-in-water emulsification followed by solvent replacement. The prepared systems were characterized by entrapment capacity (EC), entrapment efficiency (EE), particle size, polydispersity index, zeta potential, transmission electron microscopy, Fourier transform infrared spectroscopy, differential scanning calorimetry, powder X-ray diffraction, in vitro drug release, and their antibacterial activity against bacterial scrums. EC, EE, particle size, polydispersity index, zeta potential, and percentage release in 24 hours were found to be in the range of 33.5%–68.8%, 53.1%–67.1%, 43.3–243.3 nm, 0.08–0.28, 9.5–53.3 mV, and 5.8%–22.4%, respectively. One-way analysis of variance and Pareto charts revealed that the experimental loadings of 2-hydroxypropyl-β-cyclodextrin and Eudragit® S100 were the most significant for their effects on nicotinamide EC and EE. Moreover, the polymeric nanoemulsified particles demonstrated a sustained release profile for nicotinamide. The Fourier transform infrared spectroscopy, differential scanning calorimetry, and X-ray diffraction demonstrated a significant interaction between the drug and 2-hydroxypropyl-β-cyclodextrin that might modulate the sustained release behavior. Furthermore, the formulations provided a sustained antibacterial activity that depended on nicotinamide-loading concentration, release rate, and incubation time. In conclusion, the study demonstrated the potential of polymeric nanoemulsified system to sustain the release and antibacterial activity of nicotinamide.
This paper references
10.1016/j.ejpb.2009.02.013
The use of Eudragit RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione.
A. Lopedota (2009)
10.1081/DDC-100101266
A pH-Dependent Colon-Targeted Oral Drug Delivery System Using Methacrylic Acid Copolymers. II. Manipulation of Drug Release Using Eudragit® L100 and Eudragit S100 Combinations
M. Z. Khan (2000)
10.1016/0024-3205(80)90638-4
Absorption of nicotinic acid and nicotinamide across human buccal mucosa in vivo.
D. F. Evered (1980)
10.1016/j.ijpharm.2013.10.036
Docetaxel-nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery.
Xiucong Fan (2013)
10.1016/S0168-3659(98)00151-5
A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.
M. Z. Khan (1999)
10.1016/j.jconrel.2010.04.019
Hydrophobic pharmaceuticals mediated self-assembly of beta-cyclodextrin containing hydrophilic copolymers: novel chemical responsive nano-vehicles for drug delivery.
J. Zhang (2010)
10.1111/j.1572-0241.2001.03698.x
The metabolism of nicotinamide in human liver cirrhosis: a study on N-methylnicotinamide and 2-pyridone-5-carboxamide production
R. Pumpo (2001)
10.1007/s00125-011-2288-0
Nicotinamide mononucleotide protects against pro-inflammatory cytokine-mediated impairment of mouse islet function
P. Caton (2011)
Multi-morphological selfassembled structures in water of a biodegradable beta-cyclodextrinbased copolymer
MW Jiang (2012)
A NEW TOPICAL FLUCONAZOLE MICROSPONGE LOADED HYDROGEL: PREPARATION AND CHARACTERIZATION
N. S. Abdelmalak (2012)
10.1016/j.ejpb.2010.06.007
Polymeric micelles for oral drug delivery.
G. Gaucher (2010)
10.3109/10837450.2014.898656
Multivariate analysis in the pharmaceutical industry: enabling process understanding and improvement in the PAT and QbD era
A. P. Ferreira (2015)
10.1016/j.biomaterials.2014.04.072
Polymeric micelles for GSH-triggered delivery of arsenic species to cancer cells.
Q. Zhang (2014)
10.1016/S0167-8140(98)00048-6
Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy: the experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer.
J. Bernier (1998)
10.1016/j.ijrobp.2010.11.045
Acute toxicity profile and compliance to accelerated radiotherapy plus carbogen and nicotinamide for clinical stage T2-4 laryngeal cancer: results of a phase III randomized trial.
G. Janssens (2012)
10.1086/367544
Nicotinamide: an oral antimicrobial agent with activity against both Mycobacterium tuberculosis and human immunodeficiency virus.
M. Murray (2003)
10.1080/10543400802278197
A Bayesian Approach to the ICH Q8 Definition of Design Space
J. Peterson (2008)
10.1016/j.ijpharm.2014.03.008
Nicotinamide pelletization by fluidized hot melt granulation: L18 Hunter design to screen high risk variables.
A. Zidan (2014)
10.1021/la1003534
Zeta potential of mica covered by colloid particles: a streaming potential study.
Z. Adamczyk (2010)
10.1016/j.ijpharm.2015.11.012
Supercritical CO2 foamed polycaprolactone scaffolds for controlled delivery of 5-fluorouracil, nicotinamide and triflusal.
A. Salerno (2015)
10.1089/10430340460745801
Nonionic polymeric micelles for oral gene delivery in vivo.
Shwu-Fen Chang (2004)
10.3797/SCIPHARM.0808-05
Cyclodextrins as Drug Carrier Molecule: A Review
Arun Rasheed (2008)
10.1016/j.xphs.2015.11.023
Integrated Application of Quality-by-Design Principles to Drug Product Development: A Case Study of Brivanib Alaninate Film-Coated Tablets.
S. Badawy (2016)
10.4314/TJPR.V9I1.52039
Dicyclomine-loaded Eudragit ® -based Microsponge with Potential for Colonic Delivery: Preparation and Characterization
Vikas Jain (2010)
10.1111/ijd.12002
Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris
E. Khodaeiani (2013)
EMA and US FDA release initial conclusions of parallel assessment of quality-by-design applications
H. Coaker (2014)
10.1016/j.jpba.2013.11.009
Physico-chemical characterization in solution and in the solid state of clonazepam complexes with native and chemically-modified cyclodextrins.
N. Mennini (2014)
10.1007/s13277-013-1356-0
The enhanced apoptosis and antiproliferative response to combined treatment with valproate and nicotinamide in MCF-7 breast cancer cells
H. Jafary (2013)
10.1021/BM0503165
Exploiting the vitamin B12 pathway to enhance oral drug delivery via polymeric micelles.
M. Francis (2005)
10.1016/j.msec.2014.02.003
Novel Pullulan-Eudragit® S100 blend microparticles for oral delivery of risedronate: formulation, in vitro evaluation and tableting of blend microparticles.
Aline de Arce Velasquez (2014)
Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations.
B. Nath (2011)
US FDA release initial conclusions of parallel assessment of quality-by-design applications
H Coaker (2014)
10.1155/2013/848043
Formulation Strategies to Improve the Bioavailability of Poorly Absorbed Drugs with Special Emphasis on Self-Emulsifying Systems
S. Gupta (2013)
10.1016/j.ejpb.2013.08.003
Supersaturated polymeric micelles for oral cyclosporine A delivery.
H. Yu (2013)
10.1016/S0022-2860(03)00256-4
Coordination behaviour of nicotinamide: an infrared spectroscopic study
S. Bayarı (2003)
10.1016/J.EJMECH.2005.05.005
Synthesis, antibacterial, antifungal activity and interaction of CT-DNA with a new benzimidazole derived Cu(II) complex.
F. Arjmand (2005)
10.1007/s10895-010-0669-2
Unusual Spectral Shifts of Imipramine and Carbamazepine Drugs
A. Prabhu (2010)
10.1016/J.FLUID.2014.03.029
High-pressure solubility of naproxen, nicotinamide and their mixture in acetone with supercritical CO2 as an anti-solvent
Anne-Laure Revelli (2014)
10.1016/J.MOLSTRUC.2013.02.019
Synthesis, structural characterisation, bio-potential efficiency and DNA cleavage applications of nicotinamide metal complexes
C. Dilip (2013)



This paper is referenced by
10.1016/J.JDDST.2019.01.040
Resveratrol anchored nanostructured lipid carrier loaded in situ gel via nasal route: Formulation, optimization and in vivo characterization
A. Rajput (2019)
10.3390/ijms21114138
Optimized Conjugation of Fluvastatin to HIV-1 TAT Displays Enhanced Pro-Apoptotic Activity in HepG2 Cells
L. Al-Wahaibi (2020)
10.1016/j.colsurfb.2017.05.014
Improving the pharmacokinetics and tissue distribution of pyrinezolid by self-assembled polymeric micelles.
H. Long (2017)
10.3390/polym11101668
Targeted Release of Probiotics from Enteric Microparticulated Formulations
C. Yus (2019)
10.1080/17425247.2018.1546287
Novel nicotinamide skin-adhesive hot melt extrudates for treatment of acne
Maha Nasr (2018)
Preparation, Optimization and in Vitro Characterization of Cisplatin Loaded Novel Polymeric Micelles for Treatment of Lung Cancer
Rana (2016)
10.1016/j.msec.2018.06.031
Fast dissolving moxifloxacin hydrochloride antibiotic drug from electrospun Eudragit L-100 nonwoven nanofibrous Mats.
P. Giram (2018)
10.1016/j.ijbiomac.2020.04.235
Xylan-based hydrogels for potential skin care application.
G. Fu (2020)
10.1039/d0nr01366h
Development of polycationic micelles as an efficient delivery system of antibiotics for overcoming the biological barriers to reverse multidrug resistance in Escherichia coli.
R. Guo (2020)
10.1016/j.ijbiomac.2017.10.156
Preparation and optimization of self-assembled chondroitin sulfate-nisin nanogel based on quality by design concept.
Shahab Mohtashamian (2018)
Semantic Scholar Logo Some data provided by SemanticScholar